Rixathon 100 mg/10 ml

Rixathon 100 mg/10 ml is a medicine authorised by Swissmedic under authorisation number 66435. The authorisation holder is Sandoz Pharmaceuticals AG. The medicinal product code is Biotechnological medicines and the dispensing category is A: Supplied only against a medical or veterinary prescription that may not be dispensed repeatedly. First authorisation was granted on 03 July 2018 and the authorisation is valid without a time limit. ATC code L01FA01 places the medicine in the group Antineoplastic agents.

  • Dispensing category A
  • Authorisation number 66435
  • ATC L01FA01
  • Biotechnological medicines
Authorisation data
Authorisation number66435
NameRixathon 100 mg/10 ml
Full nameRixathon 100 mg/10 ml, Konzentrat zur Herstellung einer Infusionslösung
Authorisation holderSandoz Pharmaceuticals AG
Medicinal product codeBiotechnological medicines
Dispensing categoryA · Prescription, not repeatable
ATC codeL01FA01
First authorisation03 July 2018
Authorisation validityunlimited
Strengths
No.NameDispensing categoryAuthorisation date
1Rixathon 100 mg/10 ml, Konzentrat zur Herstellung einer InfusionslösungA03 July 2018
2Rixathon 500 mg/50 ml, Konzentrat zur Herstellung einer InfusionslösungA03 July 2018

Scroll the table sideways

Pack sizes
Pack codeQuantityUnitATCIT codeDispensing category
12Durchstechflasche(n)L01FA0107.16.1.A
23Durchstechflasche(n)L01FA0107.16.1.A
31Durchstechflasche(n)L01FA0107.16.1.A
42Durchstechflasche(n)L01FA0107.16.1.A

Scroll the table sideways

Medicines in the same ATC group

Other medicines from this authorisation holder

Frequently asked questions

Is Rixathon 100 mg/10 ml authorised in Switzerland?

Yes. Rixathon 100 mg/10 ml is authorised by Swissmedic under authorisation number 66435, data as of 01 September 2026. The authorisation is valid without a time limit.

Which dispensing category does Rixathon 100 mg/10 ml have?

Rixathon 100 mg/10 ml is in dispensing category A. Supplied only against a medical or veterinary prescription that may not be dispensed repeatedly.

Who is the authorisation holder of Rixathon 100 mg/10 ml?

The authorisation holder is Sandoz Pharmaceuticals AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.

Sources

Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.

Authorisation in Switzerland?

About 2 minutes. No obligation.

First, a little about your business.

Your answers stay in this page until you send your enquiry.

What would you like to achieve?

Your project

Where can we reach you?

You can go back to review your answers before sending.

* Required fields
Prefer email? info@swissmedicinesdirectory.com